医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Q-Lab Announces Launch of Korean Language Website

2012年10月05日 AM03:11
このエントリーをはてなブックマークに追加


 

CLEVELAND

Q-Lab, the worldwide leader in accelerated weathering test equipment and outdoor exposure test services, is pleased to announce the launch of a new Korean language website at www.q-lab.com/ko-kr.

The website has ten times the content of our original English site, and is also available in Chinese, Spanish, German, Italian, and French. More languages will be coming soon. Customers from Korea can now visit and learn about weathering, research our test equipment and exposure services, or search relevant industry standards in our extensive database.

Users can also find out about Q-Lab’s upcoming seminars, or simply contact our local representatives in Korea. A new applications section was created for a dozen different industries. In addition, anyone performing an outdoor or accelerated test at one of our facilities in Florida, Arizona or Germany can check their results online, through a portal on our main page.

Everything you need to know about weathering is now available in Korean.

Discover more information about Q-Lab’s accelerated weathering testers or outdoor exposure services by contacting us at info@q-lab.com, and make sure to visit our website at www.q-lab.com.

Will your product last outdoors? Don’t guess when you can test!

CONTACT

For additional editorial information contact:
Q-Lab Corporation
Karin
Strippel, Marketing Communications Specialist, 440-835-8700
kstrippel@q-lab.com
or
For
technical inquiries contact:
Q-Lab Corporation
800 Canterbury
Road
Cleveland, OH 44145 USA
Tel: 440-835-8700
Fax:
440-835-8738

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightreeがアテナヘルスと電子的患者紹介システムのインテグレーションを発表
  • PHCホールディングス株式会社: NPO法人 日本医療ネットワーク協会と、医療データ連携の実証実験に関する業務委託契約を締結
  • Dr. Reddy’s Laboratories defends its right to launch Buprenorphine and Naloxone Sublingual Film in the U.S. Market
  • Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F
  • Dr. Reddy’s Laboratories Announces USFDA Final Approval and Launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market